Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, ...
An expert discusses how advances in JAK V617F monitoring have improved the assessment of disease status and guided treatment decisions and how risk assessment tools have transformed the ability to ...
A panelist discusses how advances in JAK2 V617F and other molecular monitoring have enhanced their ability to assess ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback